Viewing Study NCT01072695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2025-12-29 @ 8:58 PM
Study NCT ID: NCT01072695
Status: COMPLETED
Last Update Posted: 2012-05-31
First Post: 2010-02-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HCV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis C View
None HCV View
None GS-9256 View
None GS-9190 View
None Genotype 1 View